State of Wyoming’s Ultragenyx Pharmaceutical RARE Stock Holding History

State of Wyoming’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-38	Closed	-$2K	–	1859
2022 Q2	$2K	Buy	38 +10	+36%	+$615	﹤0.01%	1784
2022 Q1	$2K	Buy	28 +4	+17%	+$278	﹤0.01%	1711
2021 Q4	$2K	Sell	24 -1	-4%	-$81	﹤0.01%	1779
2021 Q3	$2K	Sell	25 -13	-34%	-$1.18K	﹤0.01%	1161
2021 Q2	$4K	Buy	38 +20	+111%	+$2.08K	﹤0.01%	1089
2021 Q1	$2K	Buy	+18	New	+$2.45K	﹤0.01%	474

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State of Wyoming's RARE Position: Q3 2022 in Review

State of Wyoming sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2022, closing a stake of 38 shares — an estimated $2K sold.

State of Wyoming first reported a position in RARE in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q2 2021. 232 funds tracked by Wall St. Rank hold RARE as of Q3 2022.

State of Wyoming reported no remaining Ultragenyx Pharmaceutical position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 38 Ultragenyx Pharmaceutical shares in Q3 2022, an estimated $2K.
State of Wyoming first reported a position in Ultragenyx Pharmaceutical in Q1 2021 and held it in 6 quarters.
State of Wyoming's Ultragenyx Pharmaceutical position peaked at $4K in Q2 2021.
232 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.